Avenir Wellness Solutions, Inc. financial data

Symbol
AVRW on OTC
Industry
Pharmaceutical Preparations
Location
5805 Sepulveda Blvd., Suite 801, Sherman Oaks, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Cure Pharmaceutical Holding Corp. (to 11/21/2022), Makkanotti Group Corp. (to 11/15/2016)
Latest financial report
10-Q - Q3 2024 - Nov 19, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 7.19 % -75.7%
Quick Ratio 1.28 % -31.5%
Debt-to-equity -114 % +28.1%
Return On Assets -178 % +21.8%
Operating Margin -127 % +66.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 78.9M shares
Common Stock, Shares, Outstanding 78.9M shares +7.83%
Entity Public Float 5.7M USD -54%
Common Stock, Value, Issued 78K USD +6.85%
Weighted Average Number of Shares Outstanding, Basic 69.9M shares +16.8%
Weighted Average Number of Shares Outstanding, Diluted 69.9M shares +16.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.05M USD -50.2%
Research and Development Expense 2.02M USD -23.1%
Operating Income (Loss) -503K USD +68%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -852K USD +89.9%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -2.76M USD +73.9%
Earnings Per Share, Basic -0.26 USD/shares +66.2%
Earnings Per Share, Diluted -0.26 USD/shares +65.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 11K USD -94.2%
Accounts Receivable, after Allowance for Credit Loss, Current 33K USD -77.2%
Inventory, Net 142K USD -35.5%
Other Assets, Current 15K USD -72.7%
Assets, Current 238K USD -88%
Property, Plant and Equipment, Net 3K USD +50%
Operating Lease, Right-of-Use Asset 0 USD -100%
Intangible Assets, Net (Excluding Goodwill) 212K USD
Goodwill 0 USD -100%
Assets 748K USD -73.5%
Accounts Payable, Current 2.45M USD +56.1%
Accrued Liabilities, Current 1.59M USD -6.15%
Liabilities, Current 13.3M USD +3.96%
Operating Lease, Liability, Noncurrent 0 USD
Liabilities 13.3M USD +3.96%
Retained Earnings (Accumulated Deficit) -126M USD -2.24%
Stockholders' Equity Attributable to Parent -12.5M USD -25.9%
Liabilities and Equity 748K USD -73.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -618K USD +56%
Net Cash Provided by (Used in) Financing Activities -16K USD +74.6%
Net Cash Provided by (Used in) Investing Activities 614K USD
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 78.9M shares +7.83%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.5M USD -392%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 11K USD -94.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 7K USD +133%
Deferred Tax Assets, Valuation Allowance 10.1M USD -7.51%
Operating Lease, Liability 0 USD -100%
Depreciation 1K USD 0%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 199K USD
Operating Lease, Liability, Current 0 USD
Operating Lease, Weighted Average Discount Rate, Percent 0.14 pure +26.5%
Deferred Tax Assets, Operating Loss Carryforwards 10M USD +32.5%
Additional Paid in Capital 114M USD +0.42%
Amortization of Intangible Assets 77K USD -10%
Share-based Payment Arrangement, Expense 43K USD -94.5%
Interest Expense 44K USD 0%